MARAVAI LIFESCIENCES HOLDINGS, INC.
MRVIUS売上高
$186M
百万USD
営業利益
$-215M
百万USD
純利益
$-131M
百万USD
ROE
-61.6%
最新FY
EPS
$-0.90
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $148M | $23M | $0.24 |
| FY2021 | Q2 | $218M | $49M | $0.44 |
| FY2021 | Q3 | $205M | $54M | $0.45 |
| FY2021 | FY | $799M | $182M | $1.56 |
| FY2022 | Q1 | $244M | $67M | $0.50 |
| FY2022 | Q2 | $243M | $71M | $0.53 |
| FY2022 | Q3 | $191M | $44M | $0.34 |
| FY2022 | FY | $883M | $220M | $1.67 |
| FY2023 | Q1 | $79M | $-0M | $0.00 |
| FY2023 | Q2 | $69M | $-7M | $-0.05 |
| FY2023 | Q3 | $67M | $-6M | $-0.05 |
| FY2023 | FY | $289M | $-119M | $-0.90 |
| FY2024 | Q1 | $64M | $-12M | $-0.09 |
| FY2024 | Q2 | $73M | $-8M | $-0.05 |
| FY2024 | Q3 | $65M | $-99M | $-0.70 |
| FY2024 | FY | $259M | $-145M | $-1.05 |
| FY2025 | Q1 | $47M | $-30M | $-0.21 |
| FY2025 | Q2 | $47M | $-40M | $-0.27 |
| FY2025 | Q3 | $42M | $-26M | $-0.18 |
| FY2025 | FY | $186M | $-131M | $-0.90 |
| FY2026 | Q1 | $66M | $-4M | $-0.02 |
財務データ
| 指標 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| 売上高 | $799M | $883M | $289M | $259M | $186M |
| 営業利益 | $555M | $574M | $-32M | $-236M | $-215M |
| 純利益 | $182M | $220M | $-119M | $-145M | $-131M |
| 総資産 | $1.9B | $2.3B | $1.5B | $1.0B | $771M |
| 純資産 | $545M | $905M | $790M | $577M | $373M |
| 自己資本 | $315M | $545M | $417M | $325M | $212M |
| 営業CF | $369M | $536M | $126M | $7M | $-58M |
| EPS | $1.56 | $1.67 | $-0.90 | $-1.05 | $-0.90 |
| BPS | - | - | - | - | - |
| ROE | 57.7% | 40.4% | -28.6% | -44.5% | -61.6% |